Putative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Biofilms are microbial communities, embedded in a polymeric matrix, growing attached to a surface. Nearly all device-associated infections involve growth in the biofilm life style. Biofilm communities have characteristic architecture and distinct phenotypic properties. The most clinically important phenotype involves extraordinary resistance to antimicrobial therapy, making biofilm infections very difficulty to cure without device removal. The current studies examine drug resistance in Candida albicans biofilms. Similar to previous reports, we observed marked fluconazole and amphotericin B resistance in a C. albicans biofilm both in vitro and in vivo. We identified biofilm-associated cell wall architectural changes and increased β-1,3 glucan content in C. albicans cell walls from a biofilm compared to planktonic organisms. Elevated β-1,3 glucan levels were also found in the surrounding biofilm milieu and as part of the matrix both from in vitro and in vivo biofilm models. We thus investigated the possible contribution of β-glucans to antimicrobial resistance in Candida albicans biofilms. Initial studies examined the ability of cell wall and cell supernatant from biofilm and planktonic C. albicans to bind fluconazole. The cell walls from both environmental conditions bound fluconazole; however, four- to fivefold more compound was bound to the biofilm cell walls. Culture supernatant from the biofilm, but not planktonic cells, bound a measurable amount of this antifungal agent. We next investigated the effect of enzymatic modification of β-1,3 glucans on biofilm cell viability and the susceptibility of biofilm cells to fluconazole and amphotericin B. We observed a dose-dependent killing of in vitro biofilm cells in the presence of three different β-glucanase preparations. These same concentrations had no impact on planktonic cell viability. β-1,3 Glucanase markedly enhanced the activity of both fluconazole and amphotericin B. These observations were corroborated with an in vivo biofilm model. Exogenous biofilm matrix and commercial β-1,3 glucan reduced the activity of fluconazole against planktonic C. albicans in vitro. In sum, the current investigation identified glucan changes associated with C. albicans biofilm cells, demonstrated preferential binding of these biofilm cell components to antifungals, and showed a positive impact of the modification of biofilm β-1,3 glucans on drug susceptibility. These results provide indirect evidence suggesting a role for glucans in biofilm resistance and present a strong rationale for further molecular dissection of this resistance mechanism to identify new drug targets to treat biofilm infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, although β-1,3-glucans contribute to drug resistance and are the major cell wall polysaccharide (130), we now know that they constitute only a small fraction of the total polysaccharides present, implying that the matrix is not constructed simply of released cell wall constituents.”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One known constituent of the biofilm matrix that contributes to its drug-resistance properties is the polysaccharide β-1,3-glucan (130).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Few studies have shown that fluconazole-resistant (FR) C. albicans may also exhibit higher levels of β-glucans compared to susceptible strains (12, 16).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher levels of β-glucans absorb fluconazole and inhibit its penetration to the site of action (12).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“β-glucans can act as a physical barrier, reducing the accessibility of fluconazole to its target sites in the cell membrane and limiting its effectiveness (12).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [12]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colorimetric Method for Determination of Sugars and Related Substances
DuBois, M., Gilles, K. A., Hamilton, J. K., Rebers, P. A., & Smith, F. (1956) · Analytical Chemistry · doi:10.1021/ac60111a017 · Cited by 52,269 · cited 1×
“Carbohydrate concentrations of each fraction were measured as hexoses by the phenol-sulfuric method as previously described (18, 22 , 40).”
MethodBacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 1×
“Biofilms are structured microbial communities in which organisms irreversibly attach to a surface and become embedded in a matrix of extracellular polymeric substances produced by these cells (6, 15, 17 , 20, 21, 24, 41, 46, 50).”
BackgroundBiofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644 · cited 1×
“Biofilms are structured microbial communities in which organisms irreversibly attach to a surface and become embedded in a matrix of extracellular polymeric substances produced by these cells (6, 15, 17, 20 , 21, 24, 41, 46, 50).”
BackgroundMechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921 · cited 2×
“Previous studies in a bacterial biofilm model demonstrated sequestration of antimicrobial compounds by a cell wall component, specifically, the -1,3 glucan component of biofilm cells (33, 34 ).”
BackgroundMethods in yeast genetics : a Cold Spring Harbor Laboratory course manual
Amberg, D. C., Burke, D. J., & Strathern, J. N. (2005) · Cited by 1,803
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578 · cited 1×
“25 g/ml for fluconazole and amphotericin B, respectively [2, 6, 7, 9, 11, 15, 25, 30, 31, 47].”
BackgroundGuidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 3×
“C. albicans is a major human pathogen which can grow as a biofilm and inhabit the surface of many medical devices (28, 44 ).”
BackgroundInfluentialClinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353 · cited 1×
“A number of molecular mechanisms have been implicated in nonbiofilm antifungal resistance in C. albicans ( 54 ).”
BackgroundA genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Mah, T.-F., Pitts, B., Pellock, B., Walker, G. C., Stewart, P. S., & O'Toole, G. A. (2003) · Nature · doi:10.1038/nature02122 · Cited by 1,190
Candida biofilms and their role in infection
Douglas, L. J. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(02)00002-1 · Cited by 1,150 · cited 2×
“Biofilms are the most common form of microbial growth in nature, and the National Institutes of Health estimate that biofilms cause the majority of infections in humans ( 21 , 28, 45, 46).”
Background
Research works printed but not linked: 1
- 19. Dijkgaraff, G. J. P., J. L. Brown, and H. Bussey. 1996. The KHN1 gene of Saccharomyces cerevisiae is a functional homolog of KRE9 . Yeast. 12: 683692. · DOI · Paper page
Cited by
Items 201–300 of 414
Differential Response of Candida Species Morphologies and Isolates to Fluconazole and Boric Acid
Salama, O. E., & Gerstein, A. C. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02406-21 · Cited by 29
The battle against biofilm infections: juglone loaded nanoparticles as an anticandidal agent
Gumus, B., Acar, T., Atabey, T., Derman, S., Şahin, F., & Arasoğlu, T. (2020) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2020.04.009 · Cited by 25
Laforet, L., Moreno, I., Sánchez-Fresneda, R., Martínez-Esparza, M., Martínez, J. P., Argüelles, J.-C., de Groot, P. W. J., & Valentín-Gomez, E. (2011) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2011.00727.x · Cited by 24
“As bglucan is a component of the extracellular biofilm matrix, alterations in wall incorporation or secretion of b-glucans might also influence the biofilm-forming capacity (Nett et al., 2007).”
BackgroundLopez-Ribot, J. L. (2014) · mBio · doi:10.1128/mbio.01781-14 · Cited by 27
Rąpała‐Kozik, M., Surowiec, M., Juszczak, M., Wronowska, E., Kulig, K., Bednarek, A., Gonzalez‐Gonzalez, M., Karkowska‐Kuleta, J., Zawrotniak, M., Satała, D., et al. (2023) · Yeast · doi:10.1002/yea.3855 · Cited by 30
“The presence of β‐ glucans in the matrix is correlated with the decreased susceptibility of C. albicans to azoles and amphotericin B (Nett et al., 2007; Taff et al., 2013; Vediyappan et al., 2010).”
Da, W., Shao, J., Li, Q., Shi, G., Wang, T., Wu, D., & Wang, C. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00034 · Cited by 23
“A list of reports proposed that the sequestration of azoles by β-1,3-glucan was a newly biofilm resistance mechanism (Nett et al., 2007, 2010a,b, 2011; Mitchell et al., 2013).”
BackgroundKerkaert, J. D., Mauff, F. L., Wucher, B. R., Beattie, S. R., Vesely, E. M., Sheppard, D. C., Nadell, C. D., & Cramer, R. A. (2022) · mBio · doi:10.1128/mbio.02933-21 · Cited by 22
“In other fungi, the biofilm extracellular matrix has been determined to be a major factor in reducing antibiotic efficacy against biofilms (52, 53).”
BackgroundComparative sensitivity of 1,3 beta‐D‐glucan for common causes of candidaemia in South Africa
Chibabhai, V., Fadana, V., Bosman, N., & Nana, T. (2019) · Mycoses · doi:10.1111/myc.12982 · Cited by 23
The Ins and Outs of Azole Antifungal Drug Resistance: Molecular Mechanisms of Transport
Zavřel, M., Esquivel, B. D., & White, T. C. (2017) · Springer eBooks · doi:10.1007/978-1-4939-0694-9_29 · Cited by 24
“Recent evidence suggests that the extracellular matrix material in the biofilm, partially formed by glucans, can act as a chelator for antifungal drugs, so that the cell is not exposed to high drug concentrations (Nett et al. 2007).”
BackgroundCandida biofilm matrix as a resistance mechanism against photodynamic therapy
Garcia, B. A., Panariello, B. H. D., de Freitas-Pontes, K. M., & Duarte, S. (2021) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2021.102525 · Cited by 20
Tebbets, B., Yu, Z., Stewart, D. A., Zhao, L., Jiang, Y., Xu, L., Andes, D. R., Shen, B., & Klein, B. S. (2012) · Medical Mycology · doi:10.3109/13693786.2012.710917 · Cited by 23
Self-citationBasas, J., Morer, A., Ratia, C., Martín-Gómez, M. T., del Pozo, J. L., Gomis, X., Rojo‐Molinero, E., Torrents, E., Almirante, B., & Gavaldà, J. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw251 · Cited by 23
Alves, R. M. A., Mota, S. M. D. S., Silva, S. M., Rodrigues, C. F., Brown, A. J. P., Henriques, M., Casal, M., & Paiva, S. (2017) · Biofouling · doi:10.1080/08927014.2017.1392514 · Cited by 24
“Recent studies suggest that the composition of the extracellular matrix and its regulation might play a central role in resistance, with the polysaccharide β-1,3-glucan being linked to biofilm protection against antifungal agents (Nett et al. 2007b, 2010; Taff et al. 2012).”
BackgroundAssembly and Antifungal Effect of a New Fluconazole-Carrier Nanosystem
de Lima, T. M., Arias, L. S., Afanaci, L. F., Rf, B. F., Neto, F. N. D. S., de Lima, B. H. R., Straioto, F. G., Camargo, E. R., Pessan, J. P., & Monteiro, D. R. (2020) · Future Microbiology · doi:10.2217/fmb-2019-0182 · Cited by 21
Pezzotti, G., Kobara, M., Nakaya, T., Imamura, H., Asai, T., Miyamoto, N., Adachi, T., Yamamoto, T., Kanamura, N., Ohgitani, E., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.896359 · Cited by 20
“However, the evident formation of biofilm suggests that β-1, 3–glucans belong to an extracellular matrix network built by the cells to bind to AmB thus reducing the drug susceptibility of the clades (Nett et al., 2007).”
BackgroundMiyake, A., Gotoh, K., Iwahashi, J., Togo, A., Horita, R., Miura, M., Kinoshita, M., Ohta, K., Yamashita, Y., & Watanabe, H. (2022) · Journal of Fungi · doi:10.3390/jof8070700 · Cited by 21
Foglia, F., Drake, A. F., Terry, A. E., Rogers, S. E., Lawrence, M. J., & Barlow, D. J. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.02.012 · Cited by 23
Actividad de la micafungina contra las biopelículas de Candida
Quindós, G., Villar-Vidal, M., & Eraso, E. (2009) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(09)70008-7 · Cited by 27
Candida albicans Niche Specialization: Features That Distinguish Biofilm Cells from Commensal Cells
Herwald, S. E., & Kumamoto, C. A. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0178-x · Cited by 25
de Mello, T. P., Oliveira, S. S. C., Branquinha, M. H., & dos Santos, A. L. S. (2022) · Medical Mycology · doi:10.1093/mmy/myac036 · Cited by 20
Alves, A. M. C. V., Lopes, B. O., Leite, A. C. R. D. M., Cruz, G. S., de Brito, É. H. S., de Lima, L. F., Černáková, L., Azevedo, N. F., & Rodrigues, C. F. (2023) · Antibiotics · doi:10.3390/antibiotics12050797 · Cited by 20
“This is, for example, the case for the biofilm resistance to Flu and AmB, which is associated with a significant decrease in total ergosterol content as well as changes in the levels of other sterols by the expression of ERG genes, which act as binding sites for antifungal molecules, inhibiting their binding to ergost…”
BackgroundInfluentialBiofilm Formation as a Pathogenicity Factor of Medically Important Fungi
Vila, T. V. M., & Rozental, S. (2016) · InTech eBooks · doi:10.5772/62768 · Cited by 30
“albicans planktonic cells [92], resembling a biofilm-like behavior by the presence of the ECM.”
BackgroundIn vitro inhibitory activities of magnolol against Candida spp.
Zhou, P., Fu, J., Hua, H., & Liu, X. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s146529 · Cited by 19
“Levels of β-1,3-glucan on Candida cell walls as well as in ECM were significantly elevated in biofilm-form than in planktonic-mode, which may benefit the biofilm fluconazole-resistance.(50) Moreover,”
Micro- to nano-scale chemical and mechanical mapping of antimicrobial-resistant fungal biofilms
Pham, D. Q., Bryant, S. J., Cheeseman, S., Huang, L. Z. Y., Bryant, G., Dupont, M. F., Chapman, J., Berndt, C. C., Vongsvivut, J. P., Crawford, R. J., et al. (2020) · Nanoscale · doi:10.1039/d0nr05617k · Cited by 19
Mikulska, M., Ullah, N., Magnasco, L., Codda, G., Bartalucci, C., Miletich, F., Sepulcri, C., Willison, E., Vena, A., Giacobbe, D. R., et al. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.02.012 · Cited by 20
Uppuluri, P., & Lopez-Ribot, J. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_5 · Cited by 21
Vaginal discharge syndrome. Problem with many unknowns
Татарчук, Т. Ф., Kaluginа, L. V., Петрова, Г. А., Radchenko, V. V., Шаверська, В. В., Сорокіна, А. М., & Смирнова, О. В. (2020) · Reproductive Endocrinology · doi:10.18370/2309-4117.2020.53.94-100 · Cited by 18
DNase enhances photodynamic therapy against fluconazole‐resistant Candida albicans biofilms
Abreu‐Pereira, C. A., Klein, M. I., Lobo, C. I. V., Pereira, A. L. G., Jordão, C. C., & Pavarina, A. C. (2022) · Oral Diseases · doi:10.1111/odi.14149 · Cited by 18
Tan, Y., Ma, S., Ding, T., Ludwig, R., Lee, J., & Xu, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.815091 · Cited by 19
Biofilm: A Robust and Efficient Barrier to Antifungal Chemotherapy
Souza dos Santos, A. L., & de Mello, T. P. (2015) · Journal of Antimicrobial Agents · doi:10.4172/2472-1212.1000e101 · Cited by 19
Effect of disinfectants on biofilm development by five species of Candida
Ilknur, D. (2012) · African Journal of Microbiology Research · doi:10.5897/ajmr11.1427 · Cited by 19
“They have characteristic architecture and distinct phenotypic properties (Nett et al., 2007).”
BackgroundAnti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies
Magliani, W., Conti, S., Giovati, L., Maffei, D. L., & Polonelli, L. (2008) · Frontiers in bioscience · doi:10.2741/3199 · Cited by 20
Emerging Antifungal Drug Resistance in Aspergillus fumigatus and Among Other Species of Aspergillus
Toyotome, T., Hagiwara, D., Takahashi, H., Watanabe, A., & Kamei, K. (2018) · Current Fungal Infection Reports · doi:10.1007/s12281-018-0318-9 · Cited by 20
Application of the systematic “DAmP” approach to create a partially defective C. albicans mutant
Finkel, J. S., Yudanin, N. A., Nett, J. E., Andes, D. R., & Mitchell, A. P. (2011) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2011.07.005 · Cited by 16
“The distal 2 cm of catheter material was assayed for biofilm growth and imaged using SEM at 50 and 100 magnification as described previously (Nett et al., 2007).”
MethodSelf-citationDispersal of single and mixed non- albicans Candida species biofilms by β-1,3-glucanase in vitro
Tan, Y., Leonhard, M., Ma, S., Moser, D., & Schneider‐Stickler, B. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.10.057 · Cited by 18
Amann, V., Kissmann, A., Krämer, M., Krebs, I., Perez‐Erviti, J. A., Otero‐González, A. J., Morales-Vicente, F., Rodríguez, A., Ständker, L., Weil, T., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020318 · Cited by 16
“However, since 2016, the Clinical Practice Guideline from Management of Candidiasis from the Infectious Disease Society of America no longer recommends the use of fluconazole as first-line treatment for less sensitive strains of the genus Candida, as these yeasts can often quickly develop high tolerances [9,10].”
Backgroundd’Enfert, C., & Bougnoux, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00139-2 · Cited by 16
Hydrogen peroxide enhances the efficacy of photodynamic therapy against Candida albicans biofilms
de Sousa, T. V., Jordão, C. C., Abreu‐Pereira, C. A., Pereira, A. L. G., Barbugli, P. A., Klein, M. I., & Pavarina, A. C. (2023) · Biofouling · doi:10.1080/08927014.2023.2189011 · Cited by 15
Zerumbone Disturbs the Extracellular Matrix of Fluconazole-Resistant Candida albicans Biofilms
Abreu‐Pereira, C. A., Pereira, A. L. G., Noveletto, J. V. M., Jordão, C. C., & Pavarina, A. C. (2023) · Journal of Fungi · doi:10.3390/jof9050576 · Cited by 16
“albicans tolerance within mixed biofilms [9,50].”
BackgroundPesee, S., Angkananuwat, C., Tancharoensukjit, S., Muanmai, S., Sirivan, P., Bubphawas, M., & Tanarerkchai, N. (2016) · Medical Mycology · doi:10.1093/mmy/myv108 · Cited by 16
Nigatu, A. S., Ashar, H. K., Sethuraman, S. N., Wardlow, R., Maples, D., Malayer, J. R., & Ranjan, A. (2017) · International Journal of Hyperthermia · doi:10.1080/02656736.2017.1420249 · Cited by 15
Domenico, E. G. D., Cavallo, I., Guembe, M., Prignano, G., Gallo, M. T., Bordignon, V., D’Agosto, G., Sperduti, I., Toma, L., & Ensoli, F. (2018) · FEMS Yeast Research · doi:10.1093/femsyr/foy025 · Cited by 17
Nunes, T. S. B. S., Rosa, L. M., Vega-Chacón, Y., & Mima, E. G. D. O. (2020) · Microorganisms · doi:10.3390/microorganisms8070980 · Cited by 17
“According to Nett et al. (2007) [66] and Zarnowski et al. (2014) [12], the WSP comprises the α-mannans, and the ASP comprises 1,6-β-glucan and 1,3-β-glucan.”
BackgroundCandida Biofilm Tolerance: Comparison of Planktonic and Biofilm Resistance Mechanisms
Dominguez, E. G., & Andes, D. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_6 · Cited by 18
Self-citationAl-Otibi, F. O., Alrumaizan, G. I., & Alharbi, R. I. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03552-x · Cited by 13
Biofilms formed byScedosporiumandLomentosporaspecies: focus on the extracellular matrix
de Mello, T. P., Branquinha, M. H., & dos Santos, A. L. S. (2020) · Biofouling · doi:10.1080/08927014.2020.1759558 · Cited by 15
“D structure is mainly supported by a-(1,6)-mannan and the resistance is due to the b-(1,3)-glucan (Flemming et al. 2007; Nett et al. 2007; Tan et al. 2017).”
Backgroundde Freitas, M. A., Andrade-Pinheiro, J. C., Alves, A. I. D. S., dos Santos, F. D. A. G., de Andrade, M. C. L., Sales, D. L., Nunes, M., Ribeiro, P. R. V., Coutinho, H. D. M., Morais‐Braga, M. F. B., et al. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.134779 · Cited by 14
Silver, P. M., Oliver, B. G., & White, T. C. (2008) · Medical Mycology · doi:10.1080/13693780701816557 · Cited by 14
Jordão, C. C., Klein, M. I., Barbugli, P. A., Mima, E. G. D. O., de Sousa, T. V., Ferrisse, T. M., & Pavarina, A. C. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1274201 · Cited by 14
Exopolysaccharides and Biofilms
Mauff, F. L. (2020) · Current topics in microbiology and immunology · doi:10.1007/82_2020_199 · Cited by 15
Analysis of biofilm formation bySporothrix schenckii
Sánchez-Herrera, R., Villavicencio, L. L. F., Pichardo-Molina, J. L., Domínguez, J. P. C., Aparicio-Fernández, X., López, M. S., & Villagómez-Castro, J. C. (2020) · Medical Mycology · doi:10.1093/mmy/myaa027 · Cited by 17
Vila, T. V. M., Fonseca, B. B., da Cunha, M. M. L., dos Santos, G. R. C., Ishida, K., Barreto‐Bergter, E., de Souza, W., & Rozental, S. (2017) · Journal of Microscopy · doi:10.1111/jmi.12580 · Cited by 14
“This obstacle appears to depend on the amount and nature of the matrix, as well as physicochemical properties of the drug (Nett et al., 2007, Nett et al., 2010a; Taff et al., 2012).”
BackgroundMethodMazari, W., Boucherit‐Otmani, Z., Haci, I. A. E., Ilahi, A., & Boucherit, K. (2018) · International Dental Journal · doi:10.1111/idj.12401 · Cited by 15
Squitieri, D., Rizzo, S., Torelli, R., Mariotti, M., Sanguinetti, M., Cacaci, M., & Bugli, F. (2025) · Pharmaceuticals · doi:10.3390/ph19010008 · Cited by 12
“%) polymerized through β -1,3-glycosidic linkages to form β -1,3-glucan, which has been identified as a key factor in antifungal drug resistance because may physically interact with the antifungal and inhibit penetration to the site of action [48].”
Foglia, F., Rogers, S. E., Webster, J. R. P., Akeroyd, F., Gascoyne, K. F., Lawrence, M. J., & Barlow, D. J. (2015) · Langmuir · doi:10.1021/acs.langmuir.5b01365 · Cited by 12
Twice-daily red and blue light treatment for Candida albicans biofilm matrix development control
da Silveira, P. V., Panariello, B. H. D., Costa, C. A. G. D. A., Maule, S. M., Maule, S. M., Janal, M. N., Zanin, I. C. J., & Duarte, S. (2018) · Lasers in Medical Science · doi:10.1007/s10103-018-2610-x · Cited by 13
Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans
Akins, R. A., & Sobel, J. D. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-180-2_29 · Cited by 15
The Role of Isocitrate Lyase (ICL1) in the Metabolic Adaptation of Candida albicans Biofilms
Ishola, O. A., Ting, S. Y., Tabana, Y., Ahmed, M. A., Yunus, M. A., Mohamed, R., Than, L. T. L., & Sandai, D. A. (2016) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.38031 · Cited by 13
Micafungin for the prophylaxis and treatment ofCandidainfections
Fritz, J. M., Brielmaier, B. D., & Dubberke, E. R. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.2.153 · Cited by 15
“Recent in vitro and in vivo studies have indicated that the fungal cell walls of C. albicans isolates within biofilms contain significantly higher concentrations of 1,3-β-D glucan than planktonic cells [ 39 ,40].”
BackgroundDrug susceptibility of matrix‐encapsulated Candida albicans nano‐biofilms
Srinivasan, A., Gupta, C. M., Agrawal, C. M., Leung, K. P., Lopez‐Ribot, J. L., & Ramasubramanian, A. K. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25120 · Cited by 11
“In fact, one of the main reasons for the resistance of biofilms against FLU, and most of the drugs from azole class, is the binding of azole molecules to glucans in the self-produced exo-polymeric ‘matrix’(Nett et al. 2007).”
BackgroundInhibition of Staphylococcus aureus biofilm formation by gurmarin, a plant-derived cyclic peptide
Chang, A. W., Dowd, S. E., Brackee, G., Fralick, J. A., & Vediyappan, G. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1017545 · Cited by 12
“The pathogens produce extracellular polysaccharide materials, which play a number of roles in biofilms including sequestration of antimicrobial agents (Mah et al., 2003; Nett et al., 2007; Flemming and Wingender, 2010; Vediyappan et al., 2010).”
BackgroundSmall molecule II-6s synergises with fluconazole against Candida albicans
Yang, S., Peng, X., Ren, B., Luo, Y., & Xu, X. (2023) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2023.106820 · Cited by 11
Kumar, D., & Kumar, A. (2023) · Microbial Drug Resistance · doi:10.1089/mdr.2022.0347 · Cited by 12
Walsh, D., Parmenter, C. D. J., Bakker, S. E., Lithgow, T. J., Traven, A., & Harrison, F. (2024) · Microbiology · doi:10.1099/mic.0.001480 · Cited by 11
Liang, R., Cao, Y., Zhou, Y., Xu, Y., Gao, P., Dai, B., Yang, F. J., Tang, H. R., & Jiang, Y. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.33 · Cited by 12
Sadanandan, B., Ashrit, P., Nataraj, L. K., Shetty, K., Jogalekar, A. P., Vijayalakshmi, V., & Hemanth, B. (2022) · Korean Journal of Chemical Engineering · doi:10.1007/s11814-021-1054-3 · Cited by 12
Organization of Fungal, Oomycete and Lichen (1,3)-β-Glucans
Clavaud, C., Aimanianda, V., & Latgé, J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-373971-1.00011-x · Cited by 21
Balkrishna, A., Kharayat, B., Rastogi, S., Kabdwal, M., Haldar, S., & Varshney, A. (2023) · Journal of Applied Microbiology · doi:10.1093/jambio/lxad087 · Cited by 10
An Overview of the Antimicrobial Activity of Some Microbial Enzymes
Salah, A. N., & Alwabsi, H. A. (2024) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2024.140.150 · Cited by 12
“Identifying the elevated levels of β-1,3 glucan which are present in the surrounding biofilm environment and are part of the biofilm models in the cell wall structure of C. albicans affirms the potential role of β-Glucanase in disrupting C. albicans biofilms (Nett et al ., 2007; Tan et al ., 2022).”
BackgroundMultiple effects of a novel compound fromBurkholderia cepaciaagainstCandida albicans
Li, X., Quan, C., Yu, H., & Fan, S.-D. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01238.x · Cited by 10
Martínez, J. P., Blanes, R., Casanova, M., Valentín, E., Murgui, A., & Domínguez, Á. (2016) · FEMS Yeast Research · doi:10.1093/femsyr/fow075 · Cited by 10
López, A. D. L. R., Lee, M., Wang, N., Dunn, K. K., Sánchez, H., Raman, N., Andes, D. R., Lynn, D. M., & Palecek, S. P. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02653-18 · Cited by 12
Self-citationLiu, W., Li, M., Tian, B., Yang, X., Du, W., Wang, X., Zhou, H., Ding, C., & Sai, S. (2022) · Biomaterials Science · doi:10.1039/d2bm01263d · Cited by 10
Moura-Tamames, S. A., Ramos, M. J., & Fernandes, P. A. (2009) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2009.01.007 · Cited by 11
Zhang, Z., Yu, S., Gu, J., Tan, F., Wan, S., Gao, H., & Qin, Z. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c08008 · Cited by 10
Hernández-Benítez, J. A., Santos-Ocampo, B. N., Rosas–Ramírez, D., Ramírez‐Granillo, A., Bautista-Hernández, L. A., Lucio, V. M. B., Pérez, N. O., & Rodríguez-Tovar, A. V. (2025) · Journal of Fungi · doi:10.3390/jof11010053 · Cited by 12
Saini, S., Yadav, R., Das, R., & Singh, C. (2026) · RSC Advances · doi:10.1039/d5ra06932g · Cited by 9
Wang, Q., Wang, Z., Xu, C., Wu, D., Wang, T., Wang, C., & Shao, J. (2024) · Medical Mycology · doi:10.1093/mmy/myae014 · Cited by 9
Żarnowski, R., Jaromin, A., Zagórska, A., Dominguez, E. G., Sidoryk, K., Gubernator, J., & Andes, D. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010108 · Cited by 9
Self-citationOttaviano, E., Baron, G., Fumagalli, L., Garcia, J. L., Colombo, E. A., Artasensi, A., Aldini, G., & Borghi, E. (2021) · Microorganisms · doi:10.3390/microorganisms9071492 · Cited by 10
Alam, F., Blair, J. M. A., & Hall, R. A. (2023) · Microbiology · doi:10.1099/mic.0.001271 · Cited by 9
Candida albicans Cell Wall Mediated Virulence
Munro, C. A. (2009) · Springer eBooks · doi:10.1007/978-3-642-03150-2_4 · Cited by 11
Drug Repurposing Strategy against Fungal Biofilms
de Mello, T. P., Silva, L. N., Ramos, L. S., Frota, H. F., Branquinha, M. H., & dos Santos, A. L. S. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/156802662007200316142626 · Cited by 10
Mechanisms of Resistance to Antifungal Agents
White, T. C., & Hoot, S. J. (2011) · Wiley eBooks · doi:10.1128/9781555816728.ch127 · Cited by 10
Candida albicans enhances iron uptake to maintain fluconazole resistance
Sharma, R., Nahar, A., & Puri, S. (2025) · Infection and Immunity · doi:10.1128/iai.00002-25 · Cited by 8
Shen, X., Chen, X., Ding, T., Liu, S., & Wei, S. (2025) · Journal of Future Foods · doi:10.1016/j.jfutfo.2025.07.013 · Cited by 8
Corrêa-Almeida, C., Borba-Santos, L. P., Rollin‐Pinheiro, R., Barreto‐Bergter, E., Rozental, S., & Kurtenbach, E. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.795255 · Cited by 8
Madhuri, M., Rudramurthy, S. M., & Roy, U. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1334419 · Cited by 8
Tseng, K.-Y., Huang, Y., Huang, Y.-T., Su, Y., Wang, A.-N., Weng, W.-Y., Ke, C.-L., Yeh, Y.-C., Wang, J.-J., Du, S.-H., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012319 · Cited by 10
Candida albicans Biofilm Development and Its Genetic Control
Desai, J. V., & Mitchell, A. P. (2015) · ASM Press eBooks · doi:10.1128/9781555817466.ch5 · Cited by 14
Functional analysis of selected deletion mutants in Candida glabrata under hypoxia
Gupta, P., Meena, R. C., & Kumar, N. (2017) · 3 Biotech · doi:10.1007/s13205-017-0821-7 · Cited by 8
“Kre1 is required for the synthesis of b-1,3 glucan, which is a crucial element of the extracellular matrix and has a role in the sequestration of the antifungal molecules, causing drug resistance of the Candida biofilm (Nett et al. 2007, 2010).”
BackgroundMechanisms of Drug Resistance in Candida albicans
Sanglard, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_15 · Cited by 11
Mechanisms of Resistance to Antifungal Agents
Perlin, D. S. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch130 · Cited by 9
Formation, Resistance, and Pathogenicity of Fungal Biofilms: Current Trends and Future Challenges
Aguilar-Marcelino, L., Al‐Ani, L. K. T., Soares, F. E. D. F., Moreira, A. L. E., Téllez‐Téllez, M., Castañeda-Ramírez, G. S., Acosta-Urdapilleta, M. D. L., Díaz-Godínez, G., & Pineda-Alegría, J. A. (2021) · Fungal biology · doi:10.1007/978-3-030-60659-6_18 · Cited by 9
Review of techniques for diagnosis of catheter-related Candida biofilm infections
Nett, J. E., & Andes, D. R. (2008) · Current Fungal Infection Reports · doi:10.1007/s12281-008-0035-x · Cited by 9
Self-citationIshchuk, O. P., Sterner, O., Ellervik, U., & Manner, S. (2019) · Antibiotics · doi:10.3390/antibiotics9010010 · Cited by 7
Chen, Y., Chen, F., & Lee, C. (2020) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001283 · Cited by 7
Oliveira, L. T., Marcos, C. M., Cabral, A. K. L. F., Medina‐Alarcón, K. P., Pires, R. H., Fusco‐Almeida, A. M., & Mendes‐Giannini, M. J. S. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1354140 · Cited by 10
Ross, Z. K., Alsayegh, S., Zhao, Y., McPherson, S., Munro, C. A., & Lorenz, A. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128322 · Cited by 8
The Extracellular Matrix of Yeasts: A Key Player in the Microbial Biology Change of Paradigm
Lucas, C., & da Silva, C. F. (2023) · Frontiers in Bioscience-Elite · doi:10.31083/j.fbe1502013 · Cited by 6
Metadata
- Authors
- Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., VanHandel, M., & Andes, D.
- Affiliations
- University of Wisconsin–Madison (US)
- Departments of Medicine and Medical Microbiology and Immunology
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-02
- Volume
- 51
- Issue
- 2
- Pages
- 510-520
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC1797745
- OpenAlex
- W1999751604
- Cited by
- 407
- References
- 55
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 19 · 2023: 22 · 2022: 20 · 2021: 15 · 2020: 26 · 2019: 19 · 2018: 22 · 2017: 34 · 2016: 26 · 2015: 28 · 2014: 25 · 2013: 20 · 2012: 23
- FWCI
- 7.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (T32HL007899)
- National Institute of Allergy and Infectious Diseases (R01AI073289)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- Candida albicans, biofilm, β-1,3-glucan, antifungal resistance, fluconazole resistance, amphotericin B resistance, β-glucanase, cell wall architecture, biofilm matrix, planktonic versus biofilm cells, device-related infection, antifungal susceptibility testing
- MeSH terms
- Amphotericin B, Antifungal Agents, Candida albicans, Microbial Sensitivity Tests, Fluconazole, Biofilms, Drug Resistance, Fungal, Glucan 1,3-beta-Glucosidase, beta-Glucans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.